Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Boaz Hirshberg

Showing results (11-20 of 95) with videos related to

Pageof 10
Sort By:
Postgraduate Medicine|November 22, 2014
Saxagliptin efficacy and safety in patients with type 2 diabetes mellitus stratified by cardiovascular disease history and cardiovascular risk factors: analysis of 3 clinical trialsWilliam Cook, Gianmaria Minervini, Brian Bryzinski, et al.
Diabetes Research and Clinical Practice|June 21, 2014
Saxagliptin improves glycemic control by modulating postprandial glucagon and C-peptide levels in Chinese patients with type 2 diabetesMikaela Sjöstrand, Nayyar Iqbal, Jane Lu, et al.
Journal of Diabetes and Its Complications|August 30, 2014
Saxagliptin efficacy and safety in patients with type 2 diabetes receiving concomitant statin therapyBrian Bryzinski, Elsie Allen, William Cook, et al.
Current Diabetes Reports|August 2, 2006
Radiologic aspects of islet cell transplantationZiv Neeman, Boaz Hirshberg, David Harlan, et al.
Clinical Therapeutics|November 9, 2016
Effects of Glimepiride versus Saxagliptin on β-Cell Function and Hypoglycemia: A Post Hoc Analysis in Older Patients with Type 2 Diabetes Inadequately Controlled with MetforminShira Perl, William Cook, Cheryl Wei, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|July 13, 2016
Saxagliptin Efficacy and Safety in Patients With Type 2 Diabetes and Moderate Renal ImpairmentShira Perl, William Cook, Cheryl Wei, et al.
Diabetes/Metabolism Research and Reviews|December 31, 2013
Safety of saxagliptin: events of special interest in 9156 patients with type 2 diabetes mellitusBoaz Hirshberg, Artist Parker, Helen Edelberg, et al.
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|November 6, 2014
Postprandial dynamics of plasma glucose, insulin, and glucagon in patients with type 2 diabetes treated with saxagliptin plus dapagliflozin add-on to metformin therapyLars Hansen, Nayyar Iqbal, Ella Ekholm, et al.
Cardiovascular Diabetology|February 5, 2014
Assessment of the cardiovascular safety of saxagliptin in patients with type 2 diabetes mellitus: pooled analysis of 20 clinical trialsNayyar Iqbal, Artist Parker, Robert Frederich, et al.
The Journal of Clinical Endocrinology and Metabolism|December 6, 2002
Histopathological study of intrahepatic islets transplanted in the nonhuman primate model using edmonton protocol immunosuppressionBoaz Hirshberg, Steven Mog, Noelle Patterson, et al.
Pageof 10

Showing results (11-20 of 95) with videos related to

Sort By:
Pageof 10
Postgraduate Medicine|November 22, 2014
Saxagliptin efficacy and safety in patients with type 2 diabetes mellitus stratified by cardiovascular disease history and cardiovascular risk factors: analysis of 3 clinical trialsWilliam Cook, Gianmaria Minervini, Brian Bryzinski, et al.
Diabetes Research and Clinical Practice|June 21, 2014
Saxagliptin improves glycemic control by modulating postprandial glucagon and C-peptide levels in Chinese patients with type 2 diabetesMikaela Sjöstrand, Nayyar Iqbal, Jane Lu, et al.
Journal of Diabetes and Its Complications|August 30, 2014
Saxagliptin efficacy and safety in patients with type 2 diabetes receiving concomitant statin therapyBrian Bryzinski, Elsie Allen, William Cook, et al.
Current Diabetes Reports|August 2, 2006
Radiologic aspects of islet cell transplantationZiv Neeman, Boaz Hirshberg, David Harlan, et al.
Clinical Therapeutics|November 9, 2016
Effects of Glimepiride versus Saxagliptin on β-Cell Function and Hypoglycemia: A Post Hoc Analysis in Older Patients with Type 2 Diabetes Inadequately Controlled with MetforminShira Perl, William Cook, Cheryl Wei, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|July 13, 2016
Saxagliptin Efficacy and Safety in Patients With Type 2 Diabetes and Moderate Renal ImpairmentShira Perl, William Cook, Cheryl Wei, et al.
Diabetes/Metabolism Research and Reviews|December 31, 2013
Safety of saxagliptin: events of special interest in 9156 patients with type 2 diabetes mellitusBoaz Hirshberg, Artist Parker, Helen Edelberg, et al.
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|November 6, 2014
Postprandial dynamics of plasma glucose, insulin, and glucagon in patients with type 2 diabetes treated with saxagliptin plus dapagliflozin add-on to metformin therapyLars Hansen, Nayyar Iqbal, Ella Ekholm, et al.
Cardiovascular Diabetology|February 5, 2014
Assessment of the cardiovascular safety of saxagliptin in patients with type 2 diabetes mellitus: pooled analysis of 20 clinical trialsNayyar Iqbal, Artist Parker, Robert Frederich, et al.
The Journal of Clinical Endocrinology and Metabolism|December 6, 2002
Histopathological study of intrahepatic islets transplanted in the nonhuman primate model using edmonton protocol immunosuppressionBoaz Hirshberg, Steven Mog, Noelle Patterson, et al.
Pageof 10